Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Unity Biotechnology, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −2 vs. Q4 2023
- Shares held
- 3.58M
- −733.7K (−17.0%) vs. Q4 2023
- Total value
- $5.87M
- −$2.46M (−29.5%) vs. Q4 2023
- New holders
- 6
- 11 more added
- Sold out
- 8
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 141 | $0 | 0.00% | −320−69.4% | Reduced |
| FMR LLC | 10 | $16 | 0.00% | −27−73.0% | Reduced |
| Qube Research & Technologies Ltd | 18 | $30 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 55 | $90 | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 100 | $164 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $164 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 129 | $211 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 200 | $328 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 271 | $444 | 0.00% | +14+5.4% | Added |
| Harbour Investments, Inc. | 678 | $1.11K | 0.00% | +678 | New |
| Glen Eagle Advisors, LLC | 1,104 | $1.81K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,614 | $2.00K | 0.00% | −699−30.2% | Reduced |
| UBS Group AG | 3,494 | $5.73K | 0.00% | −5,806−62.4% | Reduced |
| Tower Research Capital LLC (TRC) | 4,912 | $8.05K | 0.00% | +2,484+102.3% | Added |
| Steward Partners Investment Advisory, LLC | 6,343 | $10.4K | 0.00% | +6,343 | New |
| LPL Financial LLC | 10,455 | $17.1K | 0.00% | +10,455 | New |
| CIBC Asset Management Inc | 10,634 | $17.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 13,085 | $21.5K | 0.00% | −121−0.9% | Reduced |
| Endowment Wealth Management, Inc. | 13,495 | $22.1K | 0.02% | +13,495 | New |
| Squarepoint Ops LLC | 13,938 | $22.9K | 0.00% | +13,938 | New |
| Susquehanna International Group, LLP | 16,440 | $27.0K | 0.00% | +482+3.0% | Added |
| Captrust Financial Advisors | 17,865 | $29.3K | 0.00% | +17,865 | New |
| Northern Trust Corp | 22,579 | $37.0K | 0.00% | +941+4.3% | Added |
| Commonwealth Equity Services, LLC | 24,612 | $40.0K | 0.00% | +1,000+4.2% | Added |
| Morgan Stanley | 37,410 | $61.4K | 0.00% | +650+1.8% | Added |
| Millennium Management LLC | 37,712 | $61.8K | 0.00% | +24,274+180.6% | Added |
| State Street Corp | 37,824 | $62.0K | 0.00% | 00.0% | Unchanged |
| Cercano Management LLC | 41,238 | $67.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 43,521 | $71.4K | 0.00% | +170.0% | Added |
| Founders Fund V Management, LLC | 49,172 | $80.6K | 7.38% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $82.0K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 70,397 | $115.5K | 0.00% | −22,303−24.1% | Reduced |
| Citadel Advisors LLC | 93,591 | $153.5K | 0.00% | +44,915+92.3% | Added |
| Renaissance Technologies LLC | 106,941 | $175.0K | 0.00% | +68,770+180.2% | Added |
| BlackRock Inc. | 112,329 | $184.2K | 0.00% | −752−0.7% | Reduced |
| Mayo Clinic | 124,081 | $203.5K | 3.31% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 134,133 | $220.0K | 0.00% | +2,351+1.8% | Added |
| Vanguard Group Inc | 557,353 | $914.1K | 0.00% | −4,249−0.8% | Reduced |
| Alyeska Investment Group, L.P. | 920,013 | $1.51M | 0.01% | −121,318−11.7% | Reduced |
| ARCH Venture Management, LLC | 1,004,817 | $1.65M | 2.05% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −688,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −28,455−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −21,569−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,971−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −8−100.0% | Sold out |